Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human IL-20R alpha Antibody, R&D Systems™

Goat Polyclonal Antibody
Supplier: R&D Systems AF1176SP
This item is not returnable.
View return policy
Description
IL-20R alpha Polyclonal specifically detects IL-20R alpha in Human samples. It is validated for Western Blot, Flow Cytometry, CyTOF-ready.Specifications
IL-20R alpha | |
Polyclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
class II cytokine receptor ZCYTOR7, CRF2-8, Cytokine receptor class-II member 8, Cytokine receptor family 2 member 8, FLJ40993, IL-20 R alpha, IL20R alpha, IL-20R1, IL-20R1IL-20 receptor subunit alpha, IL20RA, IL-20RA, IL-20R-alpha, interleukin 20 receptor, alpha, interleukin-20 receptor I, interleukin-20 receptor subunit alpha, ZcytoR7 | |
Goat | |
Affinity Purified | |
RUO | |
53832 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Western Blot, Flow Cytometry, CyTOF | |
LYOPH | |
Western Blot 0.1 ug/mL, Flow Cytometry 2.5 ug/10^6 cells, CyTOF-ready | |
Q9UHF4 | |
IL20RA | |
Mouse myeloma cell line NS0-derived recombinant human IL-20 R alpha Val30-Lys250 Accession # Q9UHF4 | |
25 μg | |
Primary | |
Detects human IL-20 R alpha in direct ELISAs and Western blots. In direct ELISAs, approximately 20% cross-reactivity with recombinant mouse IL-20 R alpha is observed. | |
Human | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction